Changes

American pharmaceutical company ''Pfizer'' and German biotechnology company ''BioNTech'' collaborated and developed the Pfizer-BioNTech COVID-19 Vaccine<ref>Centers for Disease Control and Prevention, https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/index.html</ref> and American pharmaceutical and biotechnology company ''Moderna'' developed the Moderna COVID-19 Vaccine.<ref>Centers for Disease Control and Prevention, https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/index.html</ref>  Both vaccines, based on messenger Ribonucleic Acid (mRNA) technology, were authorized by the FDA, shortly after the 2020 Presidential election was held.<ref>Adrianna Rodriguez | USA Today, Two COVID-19 vaccines are now authorized in the US; here's what we know about them, https://www.usatoday.com/story/news/health/2020/12/21/covid-vaccine-pfizer-biontech-moderna-everything-know-them/3955331001/, December 21, 2020</ref>  Following FDA approval, distribution began immediately via prearranged methods organized by the Trump Administration's COVID-19 task force.

American pharmaceutical company ''Pfizer'' and German biotechnology company ''BioNTech'' collaborated and developed the Pfizer-BioNTech COVID-19 Vaccine<ref>Centers for Disease Control and Prevention, https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/index.html</ref> and American pharmaceutical and biotechnology company ''Moderna'' developed the Moderna COVID-19 Vaccine.<ref>Centers for Disease Control and Prevention, https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/index.html</ref>  Both vaccines, based on messenger Ribonucleic Acid (mRNA) technology, were authorized by the FDA, shortly after the 2020 Presidential election was held.<ref>Adrianna Rodriguez | USA Today, Two COVID-19 vaccines are now authorized in the US; here's what we know about them, https://www.usatoday.com/story/news/health/2020/12/21/covid-vaccine-pfizer-biontech-moderna-everything-know-them/3955331001/, December 21, 2020</ref>  Following FDA approval, distribution began immediately via prearranged methods organized by the Trump Administration's COVID-19 task force.

The COVID-19 vaccines were administered by a variety of healthcare professionals that included: doctors, nurses, pharmacists, physicians assistants, and pharmacy technicians.  These professionals received training on how to administer the vaccine and how to manage very rare side effects of the vaccines.<ref>Fran Kritz | Very Well Health, Who Can Administer COVID-19 Vaccines?, https://www.verywellhealth.com/who-can-administer-covid-19-vaccines-5094165, January 4, 2021</ref>  The first U.S. vaccinations for COVID-19 were administered on December 14, 2020.  Sandra Lindsay, a critical care nurse was the first inoculated in the U.S. via the Pfizer-BioNTech COVID-19 vaccine, in New York.<ref>Ivan Pereira | ABC News, US administers 1st doses of Pfizer coronavirus vaccine, https://abcnews.go.com/US/us-administer-1st-doses-pfizer-coronavirus-vaccine/story?id=74703018, December 14, 2020</ref>

The COVID-19 vaccines were administered by a variety of healthcare professionals that included: doctors, nurses, pharmacists, physicians assistants, and pharmacy technicians.  These professionals received training on how to administer the vaccine and how to manage very rare side effects of the vaccines.<ref>Fran Kritz | Very Well Health, Who Can Administer COVID-19 Vaccines?, https://www.verywellhealth.com/who-can-administer-covid-19-vaccines-5094165, January 4, 2021</ref>  The first U.S. vaccinations for COVID-19 were administered on December 14, 2020.  Sandra Lindsay, a critical care nurse was the first inoculated, via the Pfizer-BioNTech COVID-19 vaccine, in New York during a livestreamed event with Gov. [[Andrew Cuomo]].<ref>Ivan Pereira | ABC News, US administers 1st doses of Pfizer coronavirus vaccine, https://abcnews.go.com/US/us-administer-1st-doses-pfizer-coronavirus-vaccine/story?id=74703018, December 14, 2020</ref>

In December 2020, Admiral Brett Giroir, who was on the [[White House]] COVID-19 task force, reported that the country was on track to distribute 20 million vaccine doses, at least, by the first week of January 2021 and that approximately 30 million more doses were projected for the rest of January and another 50 million in February 2021.  Additionally, it was reported that a third single-dose COVID-19 vaccine, developed by ''Johnson & Johnson'' / ''Janssen Pharmaceutical Companies of Johnson & Johnson'', could be approved for distribution as soon as January 2021.<ref>Jackie Salo | New York Post, Third COVID-19 vaccine may be approved in January, task force official says, https://nypost.com/2020/12/20/third-covid-19-vaccine-may-be-approved-in-january-official/, December 20, 2020</ref><ref>Dillon McConnell | Columbia VA Health Care System, Janssen COVID 19 Vaccine Trial, https://www.columbiasc.va.gov/features/2020/Janssen_COVID_19_Vaccine_Trial.asp, November 16, 2020</ref>  The Johnson & Johnson COVID-19 Vaccine was issued Emergency Use Authorization by the FDA in February 2021 and began shipping immediately, with plans to deliver more than 20 million doses in the U.S. in March 2021.<ref>Jaimy Lee | Market Watch, J&J plans to deliver 20 million doses of its COVID-19 vaccine in the U.S. in March, https://www.marketwatch.com/story/jj-plans-to-deliver-20-million-doses-of-its-covid-19-vaccine-in-the-us-in-march-2021-02-23, February 23, 2021</ref><ref>Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use - First Single-Shot Vaccine in Fight Against Global Pandemic, https://www.jnj.com/johnson-johnson-covid-19-vaccine-authorized-by-u-s-fda-for-emergency-usefirst-single-shot-vaccine-in-fight-against-global-pandemic, February 27, 2021</ref><ref>Berkeley Lovelace Jr. | CNBC, FDA approves Johnson & Johnson’s single-shot Covid vaccine for emergency use, https://www.cnbc.com/2021/02/27/fda-approves-jjs-single-shot-covid-vaccine-for-emergency-use.html, February 27, 2021</ref>

In December 2020, Admiral Brett Giroir, who was on the [[White House]] COVID-19 task force, reported that the country was on track to distribute 20 million vaccine doses, at least, by the first week of January 2021 and that approximately 30 million more doses were projected for the rest of January and another 50 million in February 2021.  Additionally, it was reported that a third single-dose COVID-19 vaccine, developed by ''Johnson & Johnson'' / ''Janssen Pharmaceutical Companies of Johnson & Johnson'', could be approved for distribution as soon as January 2021.<ref>Jackie Salo | New York Post, Third COVID-19 vaccine may be approved in January, task force official says, https://nypost.com/2020/12/20/third-covid-19-vaccine-may-be-approved-in-january-official/, December 20, 2020</ref><ref>Dillon McConnell | Columbia VA Health Care System, Janssen COVID 19 Vaccine Trial, https://www.columbiasc.va.gov/features/2020/Janssen_COVID_19_Vaccine_Trial.asp, November 16, 2020</ref>  The Johnson & Johnson COVID-19 Vaccine was issued Emergency Use Authorization by the FDA in February 2021 and began shipping immediately, with plans to deliver more than 20 million doses in the U.S. in March 2021.<ref>Jaimy Lee | Market Watch, J&J plans to deliver 20 million doses of its COVID-19 vaccine in the U.S. in March, https://www.marketwatch.com/story/jj-plans-to-deliver-20-million-doses-of-its-covid-19-vaccine-in-the-us-in-march-2021-02-23, February 23, 2021</ref><ref>Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use - First Single-Shot Vaccine in Fight Against Global Pandemic, https://www.jnj.com/johnson-johnson-covid-19-vaccine-authorized-by-u-s-fda-for-emergency-usefirst-single-shot-vaccine-in-fight-against-global-pandemic, February 27, 2021</ref><ref>Berkeley Lovelace Jr. | CNBC, FDA approves Johnson & Johnson’s single-shot Covid vaccine for emergency use, https://www.cnbc.com/2021/02/27/fda-approves-jjs-single-shot-covid-vaccine-for-emergency-use.html, February 27, 2021</ref>